After eating the limit for three consecutive days, “northeast yaomao” Changchun High And New Technology Industries (Group) Inc(000661) (000661. SZ) finally opened the limit on January 24, but it still fell by 7.12%, and the daily turnover exceeded 8.4 billion yuan, breaking the historical daily volume, and the turnover rate exceeded 13%.
According to statistics, the total market value of Changchun High And New Technology Industries (Group) Inc(000661) evaporated 33 billion yuan in four trading days.
Previously, due to the inclusion of growth hormone in the centralized collection of Guangdong alliance, the market was worried that Changchun High And New Technology Industries (Group) Inc(000661) performance space would be squeezed, causing shock.
The trigger is the notice on the centralized volume procurement documents of diclofenac and other drugs of Guangdong alliance released on the official website of Guangdong pharmaceutical trading center on January 19. This notice announced the relevant documents on the centralized volume procurement of diclofenac and other 276 drug alliance regions, and invited qualified enterprises to apply.
The above documents include a “detailed list of reported volume of 276 public medical institutions in drug alliance areas”, including recombinant human growth hormone injection and recombinant human growth hormone for injection of Changchun kinsay Pharmaceutical Co., Ltd., a subsidiary of Changchun High And New Technology Industries (Group) Inc(000661) .
In the announcement of abnormal stock fluctuation on January 23, Changchun High And New Technology Industries (Group) Inc(000661) explained that “according to the relevant documents in Schedules 1, 2 and 3 of the above documents, the company’s subsidiary kinsay pharmaceutical injection of recombinant human growth hormone and recombinant human growth hormone injection have been included in the scope of centralized volume procurement in the alliance area”.
Taking the 2020 revenue as an example, kinsay pharmaceutical achieved a revenue of 5.803 billion yuan and a net profit of 2.76 billion yuan, contributing 67.66% of the revenue and 90.58% of the net profit to Changchun High And New Technology Industries (Group) Inc(000661) , which is undoubtedly the core asset of Changchun High And New Technology Industries (Group) Inc(000661) .
However, Changchun High And New Technology Industries (Group) Inc(000661) stressed, “at present, the bidding procedure for centralized drug procurement has not been officially started, and the specific impact on the company’s performance will also depend on the actual participation in bidding, winning results and winning prices of kinsay pharmaceutical. The impact and impact of this centralized procurement on the company have not been determined.”
Although the impact of centralized purchase is not clear, the stock price has fallen sharply one after another, which makes the market pay attention to the stock pledge of Changchun High And New Technology Industries (Group) Inc(000661) major shareholders: if Changchun High And New Technology Industries (Group) Inc(000661) stock price continues to fall and major shareholders do not have enough collateral to make up, they may face the potential risk of passive closing positions.
According to the latest announcement on October 9, 2021, prior to September 30, 2021, Changchun High And New Technology Industries (Group) Inc(000661) Chaoda Investment Co., Ltd., the largest shareholder of Changchun High And New Technology Industries (Group) Inc(000661) pledged part of its shares to China Minsheng Banking Corp.Ltd(600016) Changchun Branch, in order to provide pledge guarantee for the bank loan of its investor Longxiang Investment Holding Group Co., Ltd.
As of the disclosure date of the announcement, Changchun High And New Technology Industries (Group) Inc(000661) the largest shareholder Changchun High And New Technology Industries (Group) Inc(000661) Chaoda Investment Co., Ltd. held a total of 76.07 million shares of the company’s non tradable shares, accounting for 18.8% of the company’s total share capital, of which the total number of pledged shares was 38.03 million, with a pledge rate of 49.99%.
On January 23, Changchun High And New Technology Industries (Group) Inc(000661) stressed through an announcement that, “For the stock pledge of the controlling shareholder of the company, after confirming with the pledgor and the indirect controlling shareholder of the company, Longxiang Investment Holding Group Co., Ltd. and Changchun New Area Development Group Co., Ltd., the relevant shareholders will take supplementary guarantee measures such as supplementary property mortgage, supplementary guarantee and prepayment to ensure that the mortgagee will not take the means of closing positions”.
In fact, in the face of falling stock prices, Changchun High And New Technology Industries (Group) Inc(000661) has launched a combination of “repurchase + overweight”. However, whether it can dispel the risk of position explosion of major shareholders still needs to be observed.
As of January 21, the announcement shows that in the range from December 3, 2021 to January 21, 2022, Changchun High And New Technology Industries (Group) Inc(000661) has repurchased 2473200 shares of the company, accounting for 0.61% of the total share capital of the company, of which the highest transaction price is 308.35 yuan / share and the lowest transaction price is 184.36 yuan / share, with a total transaction amount of about 600 million yuan (including transaction costs). So far, the repurchase scheme of Changchun High And New Technology Industries (Group) Inc(000661) has been implemented.
In addition, Changchun High And New Technology Industries (Group) Inc(000661) several executives have increased their holdings in turns.
On January 24, Li Shu, the employee representative supervisor of Changchun High And New Technology Industries (Group) Inc(000661) , held an additional 4000 shares on that day.
Coincidentally, on January 21, Changchun High And New Technology Industries (Group) Inc(000661) another announcement said that the company’s chairman Ma Ji, director and general manager Jiang Yuntao, director and Executive Deputy General Manager Ye Peng, director and deputy general manager Wang Zhigang, chairman of the board of supervisors Xie Bing, supervisor Zhao Shuping, deputy general manager Li Xiufeng, deputy general manager and chief financial officer Zhu Xinggong, Zhang Deshen, Secretary of the board of directors, added 84700 shares of the company on the same day.
Changchun High And New Technology Industries (Group) Inc(000661) said that the above personnel increased their holdings of the company based on the good trend of the company’s development and sufficient confidence in the future development, out of the rational judgment of the company’s valuation, and in order to further strengthen the awareness of market value management and boost market confidence.
